the in vitro activity of the novel monobactam carumonam ( ro17-2301 ) was evaluated on 311 gram-negative clinical isolates in comparison to aztreonam , cefotaxime , ceftazidime , cefotetan and ceftriaxone .
C0007554
cefotaxime
C0007561
ceftriaxone